 |
인쇄하기
취소
|
CJ seeks to take up more market share of flagship products
CJ CheilJedang Corp. said the combined sales of its top 10 drugs amounted to 147.3 billion won last year.
These medicines include dietary therapy Basen (23.2 billion won in sales), lipid-lowering agent Mebalothin (18.6 billion won), antihypertensive agent Herben (15.1 billion won) and anti-anemic agent Epokine (14.7 billion won).
The company also added that this year’s sales will be aide...
These medicines include dietary therapy Basen (23.2 billion won in sales), lipid-lowering agent Mebalothin (18.6 billion won), antihypertensive agent Herben (15.1 billion won) and anti-anemic agent Epokine (14.7 billion won).
The company also added that this year’s sales will be aide...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.